Topic: Drug Pricing

  • Medicare Part B Premium Dynamics Explained

  • Evaluating Industry’s Drug Pricing Claims

  • Production Plus Profit Pricing (P-quad) FAQ

  • What A Waste! The National Academy Of Medicine’s Report On Oversized Vials Of Expensive Drugs

  • Medicare Must Study Unproven, Expensive Alzheimer’s Drug

  • Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy

  • Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle

  • The Drugs at the Heart of Our Pricing Crisis

  • Biosimilars: Market Changes do not equal policy success

  • Ethics of Clinical Trials to Evaluate Biosimilars